These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Premature Vascular Aging with Features of Plaque Vulnerability in an Atheroprone Mouse Model of Hutchinson-Gilford Progeria Syndrome with Nevado RM; Hamczyk MR; Gonzalo P; Andrés-Manzano MJ; Andrés V Cells; 2020 Oct; 9(10):. PubMed ID: 33049978 [TBL] [Abstract][Full Text] [Related]
23. Vascular Smooth Muscle Cell-Specific Progerin Expression Provokes Contractile Impairment in a Mouse Model of Hutchinson-Gilford Progeria Syndrome that Is Ameliorated by Nitrite Treatment. Del Campo L; Sánchez-López A; González-Gómez C; Andrés-Manzano MJ; Dorado B; Andrés V Cells; 2020 Mar; 9(3):. PubMed ID: 32182706 [TBL] [Abstract][Full Text] [Related]
24. Hutchinson-Gilford progeria syndrome: Cardiovascular manifestations and treatment. Lian J; Du L; Li Y; Yin Y; Yu L; Wang S; Ma H Mech Ageing Dev; 2023 Dec; 216():111879. PubMed ID: 37832833 [TBL] [Abstract][Full Text] [Related]
25. Low levels of the reverse transactivator fail to induce target transgene expression in vascular smooth muscle cells. Viceconte N; McKenna T; Eriksson M PLoS One; 2014; 9(8):e104098. PubMed ID: 25090270 [TBL] [Abstract][Full Text] [Related]
26. Are There Common Mechanisms Between the Hutchinson-Gilford Progeria Syndrome and Natural Aging? Ashapkin VV; Kutueva LI; Kurchashova SY; Kireev II Front Genet; 2019; 10():455. PubMed ID: 31156709 [TBL] [Abstract][Full Text] [Related]
27. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Zhang J; Lian Q; Zhu G; Zhou F; Sui L; Tan C; Mutalif RA; Navasankari R; Zhang Y; Tse HF; Stewart CL; Colman A Cell Stem Cell; 2011 Jan; 8(1):31-45. PubMed ID: 21185252 [TBL] [Abstract][Full Text] [Related]
28. Vascular smooth muscle cell-specific progerin expression in a mouse model of Hutchinson-Gilford progeria syndrome promotes arterial stiffness: Therapeutic effect of dietary nitrite. Del Campo L; Sánchez-López A; Salaices M; von Kleeck RA; Expósito E; González-Gómez C; Cussó L; Guzmán-Martínez G; Ruiz-Cabello J; Desco M; Assoian RK; Briones AM; Andrés V Aging Cell; 2019 Jun; 18(3):e12936. PubMed ID: 30884114 [TBL] [Abstract][Full Text] [Related]
33. Molecular insights into the premature aging disease progeria. Vidak S; Foisner R Histochem Cell Biol; 2016 Apr; 145(4):401-17. PubMed ID: 26847180 [TBL] [Abstract][Full Text] [Related]
34. Towards delineating the chain of events that cause premature senescence in the accelerated aging syndrome Hutchinson-Gilford progeria (HGPS). Dreesen O Biochem Soc Trans; 2020 Jun; 48(3):981-991. PubMed ID: 32539085 [TBL] [Abstract][Full Text] [Related]
35. Progeria of stem cells: stem cell exhaustion in Hutchinson-Gilford progeria syndrome. Halaschek-Wiener J; Brooks-Wilson A J Gerontol A Biol Sci Med Sci; 2007 Jan; 62(1):3-8. PubMed ID: 17301031 [TBL] [Abstract][Full Text] [Related]
36. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833 [TBL] [Abstract][Full Text] [Related]
37. Progerin impairs chromosome maintenance by depleting CENP-F from metaphase kinetochores in Hutchinson-Gilford progeria fibroblasts. Eisch V; Lu X; Gabriel D; Djabali K Oncotarget; 2016 Apr; 7(17):24700-18. PubMed ID: 27015553 [TBL] [Abstract][Full Text] [Related]
38. Corruption of DNA end-joining in mammalian chromosomes by progerin expression. Joudeh LA; DiCintio AJ; Ries MR; Gasperson AS; Griffin KE; Robbins VP; Bonner M; Nolan S; Black E; Waldman AS DNA Repair (Amst); 2023 Jun; 126():103491. PubMed ID: 37018982 [TBL] [Abstract][Full Text] [Related]
39. Cardiac and skeletal muscle manifestations in the G608G mouse model of Hutchinson-Gilford progeria syndrome. Hong Y; Rannou A; Manriquez N; Antich J; Liu W; Fournier M; Omidfar A; Rogers RG Aging Cell; 2024 Oct; 23(10):e14259. PubMed ID: 38961628 [TBL] [Abstract][Full Text] [Related]
40. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Glynn MW; Glover TW Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]